Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study

Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders

(2013) Laura C. Politte et al.   PSYCHOPHARMACOLOGY

Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care

(2013) Macey L. Murray et al.   PSYCHOPHARMACOLOGY

Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis

(2013) Noor B. Almandil et al.   PEDIATRIC DRUGS

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence

(2012) Suzanne McCarthy et al.   BMC Psychiatry

Psychotropic Medication Use in Children With Autism in the Kentucky Medicaid Population

(2012) P. Gail Williams et al.   CLINICAL PEDIATRICS

Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment

(2012) Y. Roke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Antipsychotic-Induced Hyperprolactinemia and Testosterone Levels in Boys

(2012) Yvette Roke et al.   Hormone Research in Paediatrics

Rhabdomyolysis Reported for Children and Adolescents Treated with Antipsychotic Medicines: A Case Series Analysis

(2012) Kristina Star et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone

(2012) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Caregiver Burden as People With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder Transition into Adolescence and Adulthood in the United Kingdom

(2012) Tim Cadman et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders

(2012) Daniel L. Coury et al.   PEDIATRICS

Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial

(2012) P. Gringras et al.   BMJ-British Medical Journal

A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders

(2011) Eric Hollander et al.   AMERICAN JOURNAL OF PSYCHIATRY

High Prescription Drug Use and Associated Costs among Medicaid-Eligible Children with Autism Spectrum Disorders Identified by a Population-Based Surveillance Network

(2011) Sarah L. Logan et al.   ANNALS OF EPIDEMIOLOGY

Review on the current use of antipsychotic drugs in children and adolescents

(2011) N. B. Almandil et al.   Archives of Disease in Childhood-Education and Practice Edition

Melatonin in autism spectrum disorders: a systematic review and meta-analysis

(2011) DANIEL A ROSSIGNOL et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Mortality in Children and Adolescents Prescribed Antipsychotic Medication

(2011) Fariz A. Rani et al.   DRUG SAFETY

Prevalence and Correlates of Psychotropic Medication Use in Adolescents with an Autism Spectrum Disorder with and without Caregiver-Reported Attention-Deficit/Hyperactivity Disorder

(2011) Thomas W. Frazier et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders

(2011) M. L. McPheeters et al.   PEDIATRICS

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

(2009) Suzanne McCarthy et al.   BRITISH JOURNAL OF PSYCHIATRY

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study

(2009) Fariz A. Rani et al.   DRUG SAFETY

Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects

(2009) Yvette Roke et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Psychiatric Disorders in Children With Autism Spectrum Disorders: Prevalence, Comorbidity, and Associated Factors in a Population-Derived Sample

(2009) Emily Simonoff et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders

(2009) Eric Hollander et al.   NEUROPSYCHOPHARMACOLOGY

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Use of clonidine in children with autism spectrum disorders

(2008) Xue Ming et al.   BRAIN & DEVELOPMENT

Antipsychotics in the treatment of autism

(2008) David J. Posey et al.   JOURNAL OF CLINICAL INVESTIGATION

Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension

(2008) R Balkrishnan et al.   JOURNAL OF HUMAN HYPERTENSION

Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom

(2008) F. Rani et al.   PEDIATRICS

Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders

(2008) D. S. Mandell et al.   PEDIATRICS

A three-country comparison of psychotropic medication prevalence in youth

(2008) Julie M Zito et al.   Child and Adolescent Psychiatry and Mental Health